ATLASATLAS fair value
CN¥5.61
Above fair value · 45% premium
Range: CN¥5.05–CN¥6.18Fair valuePrice
Nanjing King-friend Biochemical Pharmaceutical (603707.SHG)
Nanjing King-friend Biochemical Pharmaceutical stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Shanghai Stock Exchange · China
CN¥8.12▼ -2.29%
Prices as of Oct 27, 2026 · CNY
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Nanjing King-friend Biochemical Pharmaceutical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Nanjing King-friend Biochemical Pharmaceutical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Nanjing King-friend Biochemical Pharmaceutical's fair value at about CN¥5.61 per share (reasonable range: CN¥5.05 to CN¥6.18). At CN¥8.12, the stock trades 45% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Nanjing King-friend Biochemical Pharmaceutical a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥7.63 and CN¥8.65; in 9 out of 10, between CN¥6.82 and CN¥9.67. Estimated annual volatility is 38%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CN¥12.8B
- Market cap (USD)
- $1.9B
- P/E ratio
- 27.5
- Dividend yield
- 1.24%
- 52-week high
- CN¥10.46
- 52-week low
- CN¥6.72
- Revenue (12 months)
- CN¥3.9B
- Gross margin
- 41.5%
- Operating margin
- 10.5%
- Net margin
- 12.3%
- Beta
- 0.44
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Nanjing King-friend Biochemical Pharmaceutical sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 603707.SHG has traded between CN¥6.72 and CN¥10.46. Today it is 22.4% below that high and 21% above its low.
On the business: net margin is 12.3%; it trades at 27.5 times earnings.
Its beta is 0.44: it tends to move less than the market.
About the company
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research, development, production, and sale of pharmaceutical raw materials and preparations in China and internationally.
Want to see everything about Nanjing King-friend Biochemical Pharmaceutical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Nanjing King-friend Biochemical Pharmaceutical (603707.SHG) fair value?
About CN¥5.61 per share according to ATLAS (reasonable range: CN¥5.05 to CN¥6.18). With the stock at CN¥8.12, it is 45% above it.
What is the chance 603707.SHG goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, 603707.SHG ends the month between CN¥7.63 and CN¥8.65.
How big is Nanjing King-friend Biochemical Pharmaceutical and what is its P/E ratio?
Nanjing King-friend Biochemical Pharmaceutical's market capitalization is CN¥12.8B. Its price-to-earnings (P/E) ratio is 27.5: you pay CN¥27.5 for each CN¥1.00 of yearly earnings.
Does Nanjing King-friend Biochemical Pharmaceutical pay a dividend?
Yes. 603707.SHG's current dividend yield is 1.24% at today's price (CN¥8.12).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer